Még nem toboroz
Robotic Bronchoscopy for Small Lung Nodules Without a Bronchus Sign
NCT07862816· Intuitive Surgical· Forrás
Contact: Ganghee Chae, MD, PhD
Még nem toboroz
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
NCT07900633· 3. fázis· Eli Lilly and Company· Forrás
Contact: ILSEONG NAMGOONG (principal investigator)
Még nem toboroz
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás
Contact: Novo Nordisk
Toboroz
Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD
NCT07539324· Genoss Co., Ltd.· Forrás
Contact: Eun-Seok Shin, MD, PhD
Toboroz
A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned
NCT07665450· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245· 2. fázis· Eli Lilly and Company· Forrás
Contact: Seung Won Ra (principal investigator)
Toboroz
LEXURE for Post-Stroke Aphasia
NCT07570264· Nunaps Inc· Forrás
Contact: Jee-Hyun Kwon, MD, PhD
Toboroz
Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)
NCT07329699· Samsung Medical Center· Forrás
Contact: Eun-Seok Shin, MD, PhD
Még nem toboroz
Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment
NCT07398001· Ulsan University Hospital· Forrás
Contact: Eun-Seok Shin, MD
Toboroz
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
NCT07687706· 3. fázis· Hanyang University Guri Hospital· Forrás
Contact: Seong-Ho Koh, MD, PhD
Toboroz
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT07222761· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
NCT07241390· 3. fázis· Eli Lilly and Company· Forrás
Contact: GYUNGMIN PARK (principal investigator)
Toboroz
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
NCT07007312· 3. fázis· Kura Oncology, Inc.· Forrás
Toboroz
Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NCT06954714· Chonnam National University Hospital· Forrás
Contact: Eun Seok Shin, MD, PhD
Fut, nem toboroz
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433· 3. fázis· Amgen· Forrás
Toboroz
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634· 3. fázis· Celcuity Inc· Forrás
Contact: Nadene Zack, MS
Toboroz
A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
NCT06550882· Takeda· Forrás
Contact: Yoo Jin Lee (principal investigator)
Toboroz
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
NCT06824168· 2. fázis· Daiichi Sankyo· Forrás
Toboroz
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
NCT07405931· Ulsan University Hospital· Forrás
Contact: Song
Toboroz
Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea
NCT07057648· Ulsan University Hospital· Forrás
Contact: Ganghee Chae, MD, PhD
Toboroz
Medipixel XA-Assisted PCI in Coronary Artery Disease
NCT06985693· CHA University· Forrás
Contact: Min-Jung Park
Toboroz
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
NCT06801834· 3. fázis· Gilead Sciences· Forrás
Toboroz
Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care
NCT06660719· 3. fázis· Shin Poong Pharmaceutical Co. Ltd.· Forrás
Contact: Neurology
Toboroz
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
NCT05672836· 4. fázis· Duk-Woo Park, MD· Forrás
Contact: Kyoung-min Park, MD
Fut, nem toboroz
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
NCT06578247· 3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
NCT06161441· 2. fázis· Regeneron Pharmaceuticals· Forrás
Meghívásos bevonás
Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion
NCT07158307· Genoss Co., Ltd.· Forrás
Toboroz
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
NCT05831085· Duk-Woo Park, MD· Forrás
Contact: Eun-seok Shin, MD
Toboroz
Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease
NCT05829889· Seung-Jung Park· Forrás
Contact: Kyung Min Park, MD
Toboroz
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
NCT06227754· Chonnam National University Hospital· Forrás
Contact: Eun Seok Shin, MD, PhD
Fut, nem toboroz
FFR Versus IVUS With Angiography-Derived FFR for Clinical Outcomes in Patients With Coronary Artery Disease
NCT06218485· Second Affiliated Hospital, Zhejiang University, School of Medicine· Forrás
Fut, nem toboroz
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
NCT06208150· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
NCT06256328· 2. fázis· Ono Pharmaceutical Co., Ltd.· Forrás
Toboroz
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
NCT06149286· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
NCT05800015· 2/3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT05785767· 2/3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
NCT05740566· 3. fázis· Amgen· Forrás
Toboroz
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
NCT05845489· 4. fázis· Seoul National University Hospital· Forrás
Contact: Eun Seok Shin, MD,PhD
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
NCT05501886· 3. fázis· Celcuity Inc· Forrás
Toboroz
OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation
NCT05418556· 4. fázis· Asan Medical Center· Forrás
Contact: Gyung Min Park, MD
Toboroz
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
NCT05044273· Jung-min Ahn· Forrás
Contact: Kyung-min Park, MD
Toboroz
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
NCT05523947· 1/2. fázis· Yuhan Corporation· Forrás
Contact: Clinical Operation Team 1
Fut, nem toboroz
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
NCT05389215· 2. fázis· Daewoong Pharmaceutical Co. LTD.· Forrás
Fut, nem toboroz
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT05321420· 2. fázis· PureTech· Forrás
Fut, nem toboroz
Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients
NCT05222555· 1/2. fázis· Incyte Corporation· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
NCT05144854· 3. fázis· Ono Pharmaceutical Co., Ltd.· Forrás
Fut, nem toboroz
Effectiveness of Antiviral Treatment in Cirrhotic Patients With Low-level Hepatitis B Virus DNA Levels
NCT04780204· 4. fázis· Asan Medical Center· Forrás
Fut, nem toboroz
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
NCT04403022· Intuitive Surgical· Forrás
Toboroz
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
NCT04416581· 4. fázis· Duk-Woo Park, MD· Forrás
Contact: Eun-seok Shin, MD
Showing 50 of 65.